Press "Enter" to skip to content

New patent for Astrazeneca Pharms drug TAGRISSO

2
Copyright © DrugPatentWatch. Originally published at New patent for Astrazeneca Pharms drug TAGRISSO

Annual Drug Patent Expirations for TAGRISSO
Annual Drug Patent Expirations for TAGRISSO

Tagrisso is a drug marketed by Astrazeneca Pharms and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.

This drug has one hundred and twenty-eight patent family members in forty-two countries.

The generic ingredient in TAGRISSO is osimertinib mesylate. One supplier is listed for this compound. Additional details are available on the osimertinib mesylate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Astrazeneca Pharms drug TAGRISSO

Comments are closed.

Find your next blockbuster

Get accurate and timely intelligence — in just a few clicks

✓ Free trial

✓ No credit card

 

DrugPatentWatch - Make Better Decisions